Recent studies indicate that TMEM16A contributed to the pathogenesis of PAH by increasing its activity, which promoted increased Cl− current in the cell membrane of PAECs from patients with iPAH. This evidence concerns the gene ANO1 and pulmonary arterial hypertension.